Venture&Growth
Location
Barcelona, Spain 
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Splice Bio is a biotech company based on intein technologies developed in the Muir Lab at Princeton University. They are working with their proprietary platform to address key limitations of current gene therapy approaches to treat patients in need. The company is building a product pipeline of gene therapies targeting inherited retinal diseases and other severe genetic diseases for which there is no cure.
More Splice Bio news
Affimed
Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate...
AM-Pharma
AM-Pharma is a Dutch biopharmaceutical company developing a biotherapeutic for the treatment of Sepsis Associated...
Amphista Therapeutics
Amphista Therapeutics is a UK-based biopharmaceutical company creating first-in-class therapeutics that harness the body’s natural...
